What our BMT Unit Do Stand for
Bone Marrow Transplantation Ghana, is a non- governmental and non-profit making Ghanaian healthcare brand that aims at revolutionizing patient-care and patient-experiences in the country with advanced treatment, state-of-the-art infrastructure and unparalleled commitment to clinical excellence. We intend to pioneer several path-breaking procedures to offer a new lease of life to people from Ghana and other sub-Sahara African nations and abroad. Connect with our International Patient Relations to understand more about how we can bring you closer to our personalized, coordinated health care and one of the world renowned medical solutions.
Delivering an excellence of clinical care is our sacred responsibility to each of our patient, and that ought to be a way of life at the Bone Marrow Transplantation Ghana medical Centre.
BMT Ghana has successfully performed the First Three Bone Marrow Transplants yesterday Wednesday July 4, 2018 to a five-and half year Ghanaian girl Josephine P. also July 8, 2018 and July 10, 2018 to Nigerian Joseph C and Miracle C respectively.
Josephine has been sucessfully discharged with full engraftment to the BMT Ghana's private facility on Wednesday 15. 08. 2018 for follow-ups.
The cure is here to stay in Ghana. This would help millions of Ghanaians and many other African patients who have met the BMT criteria to have it.
And those who have based their entire medical and political careers on telling lies or making false publications that there is no cure to Sickle Cell Diseases and other blood disorders have been disbud.
Why are folks working so hard to deny patients the truth to BMT? Some folks sit on the side-lines and root for failure and others are standing in the way of progress.
It is so frustrating the way in which BMT was mauled by critics in Ghana. Some of people’s concerns have grown out of bogus claims spread by those whose only agenda is to kill the progress and the good news BMT Ghana brings at any cost.
One thing that is clear and I am very confident about is that history is not kind and would not be to those who deny patients and their families the basic right to cure (BMT).
Of course, we have no interest whatsoever in putting pharmaceutical companies and their interest groups out of business but to give millions of poor innocent children and their families who have met the criteria for BMT a relieve and a fair chance to cure.
Well, the time for bickering is over and now is when we must bring the best ideas together to help innocent children who die every day of curable SCDs in our dear country Ghana and beyond.
At this note, we are willing to work with anyone who is genuinely willing to make this program work even better. We remain open to other ideas that accomplish our very goal.